Eli Lilly

24/7 Wall St. Abbott Laboratories (ABT) grew revenue 6.9% with medical devices up 14.8% to $5.45B. Abbott reaffirmed…

Eli Lilly’s GLP-1 drug became the world’s best-selling drug in Q3. Merck, Johnson & Johnson, AbbVie, and other…

Eli Lilly’s decision to reduce the price of its popular weight loss drug makes more sense than it…

Eli Lilly just agreed to lower the price of its blockbuster GLP-1 weight loss drug. More than half…

Shelby Knowles / Bloomberg / Getty Images Eli Lilly shares have added over a third of their value…

Trump announces lower prices coming for GLP-1 drugs Zepbound, Wegovy President Donald Trump announces discounted pricing for Zepbound…

Eli Lilly has a dominant share of the huge and expanding GLP-1 drug market. Its GLP-1 drugs will…

Michelle Carnahan has spent the better part of the last three decades working in healthcare at companies like…

AI chip maker Nvidia’s fresh partnerships with Eli Lilly and Johnson & Johnson point to a broader trend…

AI chip maker Nvidia’s fresh partnerships with Eli Lilly and Johnson & Johnson point to a broader trend…

Topline Novo Nordisk on Monday lowered the direct-to-consumer prices of its weight loss drug Wegovy and diabetes treatment…

Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients…

Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump